Home > PE Ratio > VALIANT LABORATORIES

VALIANT LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of VALIANT LABORATORIES is 160.14.

Share Price ₹142.8May 16,2024
Market Cap ₹621.2 Cr
Earnings-TTM₹3.9 CrTTM-Consolidated Results
Price/Earnings160.14xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of VALIANT LABORATORIES is calculated as :

Current Market Cap [ ₹621.2 Cr] as on May 16,2024

(/) Earnings [ ₹3.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 160.14x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for VALIANT LABORATORIES , the investors are currently willing to pay 160.14 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES


PE Ratio Performance Analysis for VALIANT LABORATORIES

- VALIANT LABORATORIES 's latest p/e ratio is 160.14x.

- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2023 averaged 0.00x.

- VALIANT LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 1 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2023 at 0x.

- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
VALIANT LABORATORIES 3.88160.14621.2
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.96368,598.0
CIPLA LTD4,155.3127.59114,654.0
DR REDDYS LABORATORIES LTD5,563.2017.5197,429.4
ZYDUS LIFESCIENCES LTD2,954.2034.36101,499.0
DIVIS LABORATORIES LTD1,382.9775.45104,348.0
MANKIND PHARMA LTD1,926.5543.5183,816.9
TORRENT PHARMACEUTICALS LTD1,494.0061.2591,505.5
LUPIN LTD1,935.5739.1375,736.5
AUROBINDO PHARMA LTD2,777.8924.4767,971.8
ABBOTT INDIA LTD1,201.2246.9656,407.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.51x
Max industry PE 160.14x
Median industry PE 40.96x
Average industry PE 51.94x



You may also like the below Video Courses